MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
8,023 Approvals
Showing 1 to 20 of 8,023 approvalsPage 1 of 402

Adenosine Cyclophosphate for Injection

Approval Number: 国药准字H20084546
Registration: Dec 30, 2022

Vitamin A Soft Capsules

Approval Number: 国药准字H20083995
Registration: Dec 30, 2022

Salbutamol Sulfate Inhalation Solution

Approval Number: 国药准字H20223943
Registration: Dec 30, 2022

Cetirizine Hydrochloride Oral Solution

Approval Number: 国药准字H20223981
Registration: Dec 30, 2022

Olmesartan Medoxomil Tablets

Approval Number: 国药准字H20223947
Registration: Dec 30, 2022

Tedizolid Phosphate Tablets

Approval Number: 国药准字H20223933
Registration: Dec 30, 2022

Pregabalin Capsules

Approval Number: 国药准字H20223957
Registration: Dec 30, 2022

Palbociclib Capsules

Approval Number: 国药准字H20223936
Registration: Dec 30, 2022

Tranexamic Acid Injection

Approval Number: 国药准字H20223969
Registration: Dec 30, 2022

Oxygen

Approval Number: 国药准字H20223970
Registration: Dec 30, 2022

Mycophenolate Mofetil Dispersible Tablets

Approval Number: 国药准字H20080281
Registration: Dec 30, 2022

Bepotastine Besilate Tablets

Approval Number: 国药准字H20223928
Registration: Dec 30, 2022

Oseltamivir Phosphate Capsules

Approval Number: 国药准字HJ20220099
Registration: Dec 30, 2022

Ertapenem Sodium for Injection

Approval Number: 国药准字H20223950
Registration: Dec 30, 2022

Felodipine Sustained-release Tablets

Approval Number: 国药准字H20223964
Registration: Dec 30, 2022

玉叶清火胶囊

Approval Number: 国药准字Z20080403
Registration: Dec 30, 2022

Tranexamic Acid Injection

Approval Number: 国药准字H20223955
Registration: Dec 30, 2022

Magnesium Sulfate Injection

Approval Number: 国药准字H20223949
Registration: Dec 30, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.